NAL norwood abbey limited

may be of interest in 0607

  1. 56,914 Posts.
    lightbulb Created with Sketch. 289
    Norwood wins key patent
    11:39, Wednesday, 28 June 2006

    Sydney - Wednesday - June 28: (RWE Australian Business News) -
    Medical technologies group Norwood Abbey Ltd [ASX:NAL] advises that a
    key patent in the microneedle portfolio licensed from the Massachusetts
    Institute of Technology (“MIT”) has been granted in the USA, with all
    key claims granted.
    The patent relates to transdermal delivery of drugs using a
    microneedle device.
    The technology is based typically on a circular device that
    inserts 2-4 very small microneedles to a very controlled depth,
    typically to a shallow depth in the top layers of the skin.
    The device and needles are held in place via vacuum while the
    drug is delivered.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.